What We Do
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases like Alzheimer’s and Parkinson’s are placing a large and increasing burden on society and, without intervention, the costs to manage these diseases will rise ten-fold within a generation.
As a part of our Healthy Aging Strategy, we aim to reduce the burden of neurodegenerative diseases of aging on Canadians by supporting the investigation of novel lifestyle approaches, and accelerating the development of therapeutics. To achieve this, we address gaps and inefficiencies in scientific research by supporting high-risk, high-reward projects while leveraging world-class business and scientific expertise. We also aim to foster innovation in funding processes, to increase philanthropic impact in health grantmaking in Canada.
What We Fund
Although our work is continuously evolving, currently we have two priorities for our funding:
- Improved lifestyle approaches
Reducing incidence and progression of neurodegenerative diseases of aging through improved lifestyle approaches
- Novel medical interventions
Reducing incidence and progression of neurodegenerative diseases of aging through novel medical interventions
For current funding opportunities, please see our Grant Calls.